Cargando…

The net benefit of thrombolysis in the management of intermediate risk pulmonary embolism: Systematic review and meta‐analysis

BACKGROUND: Benefit of thrombolytic therapy in patients with massive pulmonary embolism (PE) is evident. However, evidence supporting benefit in clinical outcomes of this approach in intermediate risk PE is lacking. OBJECTIVE: To determine the impact of thrombolysis on overall survival in intermedia...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alcedo, Pedro E., García‐Perdomo, Herney Andrés, Rojas‐Hernandez, Cristhiam M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Sickle Cell, Thrombosis, and Haematology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176023/ https://www.ncbi.nlm.nih.gov/pubmed/35844995 http://dx.doi.org/10.1002/jha2.97

Ejemplares similares

Bleeding outcomes in thrombocytopenic acute leukemic patients with venous thromboembolism
por: Wilson, Nathaniel R., et al.
Publicado: (2020)

Blood group type A secretors are associated with a higher risk of COVID‐19 cardiovascular disease complications
por: Mankelow, Tosti J., et al.
Publicado: (2021)

Plasma exchange for COVID‐19 thrombo‐inflammatory disease
por: Arulkumaran, Nishkantha, et al.
Publicado: (2020)

Is sickle cell disease a risk factor for severe COVID‐19 outcomes in hospitalized patients? A multicenter national retrospective cohort study
por: Abdulrahman, Abdulkarim, et al.
Publicado: (2021)

Clusters of pain trajectories among patients with sickle cell disease hospitalized for vaso‐occlusive crisis: A data‐driven approach
por: Rodday, Angie Mae, et al.
Publicado: (2020)

Patterns of healthcare utilization among patients with sickle cell disease hospitalized with pain crises
por: Rodday, Angie Mae, et al.
Publicado: (2020)

Mild anemia as a single independent predictor of mortality in patients with COVID‐19
por: Tremblay, Douglas, et al.
Publicado: (2021)

In‐hospital mortality in SARS‐CoV‐2 stratified by hemoglobin levels: A retrospective study
por: Al‐Jarallah, Mohammed, et al.
Publicado: (2021)

The effect of underlying inflammation on iron metabolism, cardiovascular risk and renal function in patients with type 2 diabetes
por: Ndevahoma, Fransina, et al.
Publicado: (2021)

Age‐specific differences in the magnitude of malaria‐related anemia during low and high malaria seasons in rural Zambian children
por: Acheampong, Clement O., et al.
Publicado: (2021)

Acute dilated cardiomyopathy in the setting of catastrophic antiphospholipid syndrome and thrombotic microangiopathy: A case series and review
por: Hermel, Melody, et al.
Publicado: (2020)

A pilot clinical phase II trial MemSID: Acute and durable changes of red blood cells of sickle cell disease patients on memantine treatment
por: Mahkro, Asya, et al.
Publicado: (2020)

Alpha‐globin gene triplication and its effect in beta‐thalassemia carrier, sickle cell trait, and healthy individual
por: Hamid, Mohammad, et al.
Publicado: (2021)

A novel cause of DKC1‐related bone marrow failure: Partial deletion of the 3′ untranslated region
por: Arthur, Jonathan W., et al.
Publicado: (2021)

Von Willebrand disease type Vicenza: In search of a classification for the archetype of reduced von Willebrand factor survival
por: Casonato, Alessandra, et al.
Publicado: (2021)

Assessing thrombogenesis and treatment response in congenital thrombotic thrombocytopenic purpura
por: Alwan, Ferras, et al.
Publicado: (2021)

Thrombotic microangiopathies: First report of 294 cases from a single institution experience in Argentina
por: Dos Santos, Célia, et al.
Publicado: (2021)

A retrospective analysis of venous thromboembolism trends in chemotherapy‐induced anemia: Red blood cell transfusion versus erythrocyte stimulating agent administration
por: Bryer, Emily J., et al.
Publicado: (2020)

Gabapentin for acute pain in sickle cell disease: A randomized double‐blinded placebo‐controlled phase II clinical trial
por: Puri, Latika, et al.
Publicado: (2021)

Altered type 1 interferon responses in alloimmunized and nonalloimmunized patients with sickle cell disease
por: Madany, Emaan, et al.
Publicado: (2021)

Erytra blood group analyser and kode technology testing of SARS‐CoV‐2 antibodies among convalescent patients and vaccinated individuals
por: Weinstock, Christof, et al.
Publicado: (2021)

Paroxysmal nocturnal haemoglobinuria, diagnosis and haematological findings, first report from Iran, model for developing countries
por: Jahangirpour, Mohammadali, et al.
Publicado: (2022)

Resource utilization and treatment costs of patients with severe hemophilia A: Real‐world data from the ATHNdataset
por: Recht, Michael, et al.
Publicado: (2022)

Facilitating EMA binding test performance using fluorescent beads combined with next‐generation sequencing
por: Glenthøj, Andreas, et al.
Publicado: (2021)

Degradation of red blood cell deformability during cold storage in blood bags
por: Islamzada, Emel, et al.
Publicado: (2021)

Impact of aspirin on bleeding and blood product usage in off‐pump and on‐pump coronary artery bypass graft surgery
por: Little, Christopher, et al.
Publicado: (2022)

Cytopenia associated with copper deficiency
por: Uchino, Kaori, et al.
Publicado: (2021)

Comparison of inhibitory effects of irreversible and reversible Btk inhibitors on platelet function
por: Tullemans, Bibian M.E., et al.
Publicado: (2021)

A practical and effective strategy in East Asia to prevent anti‐D alloimmunization in patients by C/c phenotyping of serologic RhD‐negative blood donors
por: Ito, Shoichi, et al.
Publicado: (2021)

Homozygous sickle cell disease related mortality in Senegal (2011–2020)
por: Seck, Moussa, et al.
Publicado: (2021)

Routine management, healthcare resource use and patient and carer‐reported outcomes of patients with transfusion‐dependent β‐thalassaemia in the United Kingdom: A mixed methods observational study
por: Shah, Farrukh, et al.
Publicado: (2021)

GDF‐15 is associated with atherosclerosis in adults with transfusion‐dependent beta‐thalassemia
por: Efat, Alaa, et al.
Publicado: (2022)

Cryoprecipitate as an alternative to platelet transfusion in thrombocytopenia
por: Crispin, Philip, et al.
Publicado: (2021)

Complement activation during cardiopulmonary bypass and association with clinical outcomes
por: Kefalogianni, Rengina, et al.
Publicado: (2022)

Fibrin clot characteristics and anticoagulant response in a SARS‐CoV‐2‐infected endothelial model
por: McCafferty, Conor, et al.
Publicado: (2022)

Targeting TRPV1 activity via high‐dose capsaicin in patients with sickle cell disease
por: Glaros, Alexander K., et al.
Publicado: (2022)

NTBI levels in C282Y homozygotes after therapeutic phlebotomy
por: Ryan, Eleanor, et al.
Publicado: (2022)

Unmet needs in the management of immune‐mediated thrombotic thrombocytopenic purpura and the potential role of caplacizumab in the UK—A modified‐Delphi study
por: Scully, Marie, et al.
Publicado: (2022)

Management of acute sickle cell priapism in an African (Togo) pediatric department includes conservative measures and intracavernous epinephrine which is safe and efficacious
por: Guedenon, Koffi Mawuse, et al.
Publicado: (2022)

Hematopoietic stem progenitor cells with malignancy‐related gene mutations in patients with acquired aplastic anemia are characterized by the increased expression of CXCR4
por: Katagiri, Takamasa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2lc8sf3aen9m3t8hqosrgot5sq